PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Chemical substance: Ibandronic acid
Presentation Product Chemical substance Chapter Items dispensed
Ibandronic acid 150mg tablets
0606020W0AAADAD
Ibandronic acid Ibandronic acid Endocrine System 34,370
Ibandronic acid 50mg tablets
0606020W0AAABAB
Ibandronic acid Ibandronic acid Endocrine System 17,977
Bonviva 150mg tablets
0606020W0BCAAAD
Bonviva Ibandronic acid Endocrine System 659
Bondronat 50mg tablets
0606020W0BBABAB
Bondronat Ibandronic acid Endocrine System 60
Iasibon 50mg tablets
0606020W0BDAAAB
Iasibon Ibandronic acid Endocrine System 12
Ibandronic acid 3mg/3ml inj pre-filled syringes
0606020W0AAAEAE
Ibandronic acid Ibandronic acid Endocrine System 11
Quodixor 150mg tablets
0606020W0BEAAAD
Quodixor Ibandronic acid Endocrine System 10
Bondronat 2mg/2ml concentrate for inf vials
0606020W0BBADAF
Bondronat Ibandronic acid Endocrine System No data available
Bondronat 2mg/2ml solution for infusion ampoules
0606020W0BBAAAA
Bondronat Ibandronic acid Endocrine System No data available
Bondronat 6mg/6ml concentrate for inf vials
0606020W0BBACAC
Bondronat Ibandronic acid Endocrine System No data available
Bonviva 3mg/3ml solution for injection pre-filled syringes
0606020W0BCABAE
Bonviva Ibandronic acid Endocrine System No data available
Ibandronic acid 2mg/2ml solution for infusion ampoules
0606020W0AAAAAA
Ibandronic acid Ibandronic acid Endocrine System No data available
Ibandronic acid 2mg/2ml solution for infusion vials
0606020W0AAAFAF
Ibandronic acid Ibandronic acid Endocrine System No data available
Ibandronic acid 6mg/6ml solution for infusion vials
0606020W0AAACAC
Ibandronic acid Ibandronic acid Endocrine System No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.